Healthcare Realty Trust (NYSE:HR - Get Free Report) was downgraded by investment analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a research report issued to clients and investors on Friday, Marketbeat reports. They presently have a $19.00 target price on the real estate investment trust's stock. JPMorgan Chase & Co.'s target price points to a potential upside of 12.56% from the company's current price.
Separately, Wells Fargo & Company restated an "underweight" rating and issued a $17.00 price target (up previously from $16.00) on shares of Healthcare Realty Trust in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat, Healthcare Realty Trust presently has a consensus rating of "Hold" and an average target price of $17.50.
Check Out Our Latest Stock Analysis on Healthcare Realty Trust
Healthcare Realty Trust Trading Up 1.1 %
Shares of NYSE:HR traded up $0.18 during trading on Friday, hitting $16.88. 11,849,084 shares of the stock were exchanged, compared to its average volume of 3,509,541. Healthcare Realty Trust has a 12-month low of $12.77 and a 12-month high of $18.90. The company has a market cap of $5.98 billion, a PE ratio of -10.68 and a beta of 0.93. The company has a fifty day moving average price of $17.72 and a two-hundred day moving average price of $17.52.
Insider Activity at Healthcare Realty Trust
In related news, Director Thomas N. Bohjalian acquired 7,750 shares of the business's stock in a transaction dated Friday, November 22nd. The shares were acquired at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the acquisition, the director now directly owns 50,002 shares in the company, valued at approximately $869,534.78. The trade was a 18.34 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Peter F. Sr Lyle, Sr. purchased 10,000 shares of the company's stock in a transaction that occurred on Friday, December 13th. The shares were bought at an average cost of $17.21 per share, with a total value of $172,100.00. Following the transaction, the director now directly owns 26,576 shares of the company's stock, valued at $457,372.96. The trade was a 60.33 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 18,750 shares of company stock valued at $323,723 over the last quarter. Insiders own 0.56% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the company. Fifth Third Wealth Advisors LLC purchased a new position in Healthcare Realty Trust in the second quarter valued at approximately $204,000. Baillie Gifford & Co. grew its stake in shares of Healthcare Realty Trust by 10.9% in the second quarter. Baillie Gifford & Co. now owns 38,442 shares of the real estate investment trust's stock valued at $634,000 after buying an additional 3,783 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Healthcare Realty Trust by 5.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 4,492,116 shares of the real estate investment trust's stock worth $74,030,000 after acquiring an additional 216,662 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Healthcare Realty Trust by 38.1% during the second quarter. Allspring Global Investments Holdings LLC now owns 2,276 shares of the real estate investment trust's stock valued at $38,000 after purchasing an additional 628 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Healthcare Realty Trust by 6.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 211,989 shares of the real estate investment trust's stock valued at $3,494,000 after purchasing an additional 12,071 shares in the last quarter.
About Healthcare Realty Trust
(
Get Free Report)
Healthcare Realty NYSE: HR is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.
See Also
Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.